Concepedia

Simon M. Poucher

SM

32

Publications

1.5K

Citations

22

H-Index

1984

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

University of Nottingham

Queen's Medical Centre

Bristol-Myers Squibb (United States)

Nottingham Biomedical Research Centre

Simon M. Poucher is an author at AstraZeneca (United Kingdom) specializing in medicine, metabolism, and physiology.

Top concepts

Publications per year

1984–2017

32

Publications

32

The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A<sub>2a</sub>selective adenosine receptor antagonist

Simon M. Poucher, J R Keddie, Parminder Singh et al. · British Journal of Pharmacology · 1995 · 362 citations · Full text

125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor.

T M Palmer, Simon M. Poucher, Kenneth A. Jacobson et al. · Molecular Pharmacology · 1995 · 89 citations

Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats

Victor P. Bilan, Eman Salah, Sheldon Bastacky et al. · Journal of Endocrinology · 2011 · 84 citations · Full text

, , +21

The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats

Franka. MacDonald, Joanne E. Peel, H. B. Jones et al. · Diabetes Obesity and Metabolism · 2010 · 83 citations

Increased acetyl group availability enhances contractile function of canine skeletal muscle during ischemia.

James A. Timmons, Simon M. Poucher, Dumitru Constantin‐Teodosiu et al. · Journal of Clinical Investigation · 1996 · 78 citations · Full text

, , +16

Rows per page

1–5 of 32